Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sintofarm Farmaceutici appears to be an Italian pharmaceutical company associated historically with marketed prescription medicines and, in its current active legal form, with wholesale distribution of pharmaceutical products. Historical regulatory records identify Sintofarm Farmaceutici S.p.A. in Guastalla, Italy as the marketing authorization holder for products including Fluixol, Cefodie, Velamox, Zinadiur, and Zinadril. More recent Italian business-directory records show an active company named Sintofarm Farmaceutici S.r.l. Societa' di Socio Unico based in Rome, classified under wholesale of pharmaceutical goods. Based on the available evidence, this is a commercial pharmaceutical/distribution business rather than a venture-backed biotech with a disclosed R&D pipeline. Publicly available information does not support an active innovative drug-development platform or clinical-stage pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sintofarm Farmaceutici.